Fill in the form below and our experts will get back to you within 1 business day.
Make precise single-base changes in genomic DNA without double-strand breaks. Our base editing platform enables C→T and A→G conversions with high efficiency and exceptional safety.
Trusted by leading research institutions
C→T / G→A conversions
A→G / T→C conversions
All 12 mutation types
Base editing enables precise single-nucleotide changes without creating risky DNA double-strand breaks, offering a safer alternative to traditional CRISPR-Cas9.
Base editing uses a modified Cas9 protein fused to a deaminase enzyme to chemically convert one DNA base to another. Unlike traditional CRISPR, no DNA double-strand breaks are created, eliminating the risk of chromosomal rearrangements and unwanted indels.
We provide comprehensive base editing services with expert gRNA design, high-quality reagents, and thorough quality control. Our team helps you select the optimal base editor and delivery strategy for your specific research or therapeutic goals.
Eliminates chromosomal translocations and large deletions associated with Cas9 nuclease.
Single-base precision with minimal indel formation and high purity editing outcomes.
High-fidelity variants with comprehensive off-target analysis for maximum safety.
Get a customized quote for your base editing project.
Multiple base editing technologies to match your experimental needs.
Convert C·G to T·A base pairs using APOBEC1 deaminase fused to Cas9 nickase. Ideal for correcting transition mutations.
Convert A·T to G·C base pairs using engineered TadA deaminase. Complements CBE for comprehensive mutation coverage.
Make all 12 types of point mutations plus small insertions and deletions without donor DNA templates.
Comprehensive specifications to meet your research and therapeutic requirements.
| Parameter | Specification |
|---|---|
| Base Editor Types | CBE (BE4, BE4-Gam), ABE (ABE7.10, ABE8e), Prime Editors (PE2, PE3) |
| Editing Window | 3-12 nucleotides depending on base editor variant |
| PAM Requirements | NGG (SpCas9), NRN (SpRY), ATN (SpG) options available |
| Delivery Formats | Plasmid DNA, mRNA + gRNA, RNP (ribonucleoprotein), LNP |
| Quality Control | NGS on-target, GUIDE-seq off-target, RNA-seq analysis |
| Turnaround Time | 2-8 weeks depending on project complexity |
Our proven workflow ensures quality and efficiency at every stage.
Discuss target mutation and base editor selection
gRNA design and off-target prediction
Base editor and gRNA preparation
Editing efficiency and off-target analysis
Reagents with comprehensive QC report
Base editing powers discovery and therapeutic development across multiple fields.
Base editing enables precise correction of disease-causing point mutations for potential curative therapies. Multiple base editing therapies are now in clinical trials.
Create precise disease models by introducing specific pathogenic mutations. Study gene function and disease mechanisms with single-base precision.
Develop improved crop varieties with precise genetic modifications. Introduce beneficial traits without disrupting the genome.
Trusted by researchers worldwide for quality and reliability.
"The base editing efficiency was outstanding. We achieved over 60% C→T conversion with minimal indels. The off-target analysis was comprehensive and helped us select the best gRNA for our therapeutic program."
"Excellent technical support throughout our project. The team helped us navigate the choice between CBE and ABE for our target mutation. Fast turnaround and detailed QC reports exceeded our expectations."
"We've used CD Biosynsis for multiple base editing projects. The consistency in editing efficiency and the thorough off-target analysis have been critical for our IND-enabling studies. Highly recommended."
Our platform is backed by peer-reviewed research.
First demonstration of cytosine base editing enabling precise C→T conversions without DSBs.
Development of adenine base editors through directed evolution of TadA deaminase.
Find answers to common questions about our service.
Get in touch with our team to discuss your requirements and receive a customized quote.
Get a customized quote for your Base Editing Service project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.